Prevention of Cardiovascular Diseases in Children and Adolescents

High Blood Press Cardiovasc Prev. 2019 Jun;26(3):191-197. doi: 10.1007/s40292-019-00316-6. Epub 2019 Apr 30.

Abstract

The atherosclerotic alterations that are the basis of cardiovascular diseases can start already in childhood. For this reason the prevention of cardiovascular diseases should be undertaken very early both in the general population and, in a targeted manner, in subjects at cardiovascular risk. Preventive strategies should include measures to encourage physical activity and correct eating habits and to reduce exposure to pollutants. The main actors responsible for carrying out these preventive interventions are the local and national political authorities. Moreover, particular attention should be paid to the first thousand days of life starting from conception, to prevent unfavorable epigenetic modifications. In addition to initiatives aimed at the general population, interventions should be planned by the medical community to assess the individual risk profile. The current obesity epidemic has in fact made it relatively frequent even among children and adolescents to find some cardiovascular risk factors known in adults such as arterial hypertension, dyslipidemia, glucose metabolism disorders and increased of uric acid values. The purpose of this review is to indicate lines of intervention for cardiovascular prevention in children and adolescents.

Keywords: Cardiovascular risk; Children; Hypertension; Metabolic syndrome; Prevention.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Age of Onset
  • Arterial Pressure
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / prevention & control*
  • Child
  • Comorbidity
  • Dyslipidemias / blood
  • Dyslipidemias / epidemiology
  • Dyslipidemias / therapy
  • Glucose Metabolism Disorders / blood
  • Glucose Metabolism Disorders / epidemiology
  • Glucose Metabolism Disorders / therapy
  • Health Status
  • Humans
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Hypertension / therapy
  • Hyperuricemia / blood
  • Hyperuricemia / epidemiology
  • Hyperuricemia / therapy
  • Lipids / blood
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / physiopathology
  • Metabolic Syndrome / therapy*
  • Pediatric Obesity / epidemiology
  • Pediatric Obesity / physiopathology
  • Pediatric Obesity / therapy
  • Preventive Health Services / methods*
  • Protective Factors
  • Risk Factors
  • Uric Acid / blood
  • Weight Gain

Substances

  • Biomarkers
  • Blood Glucose
  • Lipids
  • Uric Acid